Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis
- PMID: 15692960
- DOI: 10.1016/j.semarthrit.2004.08.005
Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis
Abstract
Background: Ankylosing spondylitis (AS) is a chronic inflammatory disorder that affects approximately 350,000 patients in the United States. Over time, the spinal and peripheral joint involvement of AS may cause severe disability and functional limitations. Research in the molecular and cellular events of AS has uncovered a distinct role for the proinflammatory cytokine, tumor necrosis factor (TNF), in the pathogenesis of this disease.
Objectives: This article reviews the role of TNF in the pathogenesis of AS and evaluates new therapeutic options for the disease.
Methods: Literature searches were conducted and various studies were reviewed and evaluated from the perspective of study design and validity of conclusions. Data are presented from animal studies and human clinical trials designed to test the efficacy of TNF inhibition in AS.
Results: The TNF inhibitors etanercept and infliximab not only demonstrate a significant reduction in the signs and symptoms of AS but also improve quality of life while reducing serious toxicities. Etanercept is the first TNF inhibitor to be approved by the United States Food and Drug Administration (FDA) for use in the treatment of AS and has recently been approved in the European Union. Infliximab has also been approved for use in the European Union.
Conclusions: Early treatment with TNF inhibitors in patients with RA has been shown to result in significant improvements in disability, pain, and joint scores compared with delayed treatment. Ongoing trials are currently investigating whether these agents can halt or delay disease progression in patients with AS.
Relevance: Understanding the role of TNF inhibition in AS has led to new therapies that offer improved function and less disability for many patients suffering from this disease.
Similar articles
-
[Anti-TNF alfa therapy in ankylosing spondylitis].Acta Med Port. 2006 Mar-Apr;19(2):141-50. Epub 2006 Aug 18. Acta Med Port. 2006. PMID: 17187716 Review. Portuguese.
-
[Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2451-4. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17156669 Chinese.
-
Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.J Rheumatol. 2003 Jun;30(6):1356-63. J Rheumatol. 2003. PMID: 12784417 Review.
-
The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.Arthritis Rheum. 2005 Aug;52(8):2506-12. doi: 10.1002/art.21209. Arthritis Rheum. 2005. PMID: 16052584 Clinical Trial.
-
Tumour necrosis factor inhibitors in ankylosing spondylitis.Intern Med J. 2008 Oct;38(10):781-9. doi: 10.1111/j.1445-5994.2008.01639.x. Epub 2008 Apr 14. Intern Med J. 2008. PMID: 18422565 Review.
Cited by
-
The synergistic role of TNFA - 308G/A and IL10 - 1082A/G polymorphisms in ankylosing spondylitis.Rheumatol Int. 2021 Dec;41(12):2215-2224. doi: 10.1007/s00296-021-04984-3. Epub 2021 Sep 4. Rheumatol Int. 2021. PMID: 34480606
-
Glial-derived TNF/Eiger signaling promotes somatosensory neurite sculpting.Cell Mol Life Sci. 2025 Jan 21;82(1):47. doi: 10.1007/s00018-024-05560-1. Cell Mol Life Sci. 2025. PMID: 39833565 Free PMC article.
-
Axial Spondyloarthritis: an overview of the disease.Rheumatol Int. 2024 Sep;44(9):1607-1619. doi: 10.1007/s00296-024-05601-9. Epub 2024 Apr 30. Rheumatol Int. 2024. PMID: 38689098 Review.
-
A Human Monoclonal Antibody Against Tumor Necrosis Factor-alpha.P T. 2009 Nov;34(11):2-30. P T. 2009. PMID: 20140139 Free PMC article. No abstract available.
-
Preliminary clinical measurement of the expression of TNF-related apoptosis inducing ligand in patients with ankylosing spondylitis.J Clin Lab Anal. 2008;22(2):138-45. doi: 10.1002/jcla.20231. J Clin Lab Anal. 2008. PMID: 18348311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials